Abstract

Improved PBPK model of carbamazepine as a strong CYP3A inducer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Population pharmacokinetics of naloxegol in a population of 1247 healthy subjects and patients.
Sunny Chapel ... Hongmei Xu
British journal of clinical pharmacology | VOL. 81
Sunny Chapel, et. al.Sunny Chapel ... Hongmei Xu
27 Oct 2015
Effects of CYP3A Inhibition, CYP3A Induction, and Gastric Acid Reduction on the Pharmacokinetics of Ripretinib, a Switch Control KIT Tyrosine Kinase Inhibitor.
Jing Wang ... Rodrigo Ruiz‐Soto
Clinical pharmacology in drug development | VOL. 11
Jing Wang, et. al.Jing Wang ... Rodrigo Ruiz‐Soto
13 May 2022
Physiologically Based Pharmacokinetic Modeling and Simulation of Mavacamten Exposure with Drug-Drug Interactions from CYP Inducers and Inhibitors by CYP2C19 Phenotype.
Caroline Sychterz ... Manting Chiang
Clinical pharmacology and therapeutics | VOL. 114
Caroline Sychterz, et. al.Caroline Sychterz ... Manting Chiang
06 Aug 2023
Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions with Moderate CYP3A4 Inhibitors or Inducers.
Karen Yeo ... Devin Welty
Paediatric drugs | VOL. 20
Karen Yeo, et. al.Karen Yeo ... Devin Welty
02 Nov 2017
View more papers

More From: Drug Metabolism and Pharmacokinetics

Paper Title
Journal
Date
Author
Insights into drug development with quantitative systems pharmacology: A prospective case study of uncovering hyperkalemia risk in diabetic nephropathy with virtual clinical trials
Ryuta Saito ... Tomohisa Nakada
Drug Metabolism and Pharmacokinetics | VOL. 56
Ryuta Saito, et. al.Ryuta Saito ... Tomohisa Nakada
09 May 2024
Practical QSP application from the preclinical phase to enhance the probability of clinical success: Insights from case studies in oncology
Masayo Oishi ... Yasuhisa Nagasaka
Drug Metabolism and Pharmacokinetics | VOL. -
Masayo Oishi, et. al.Masayo Oishi ... Yasuhisa Nagasaka
01 May 2024
Physiologically Based Pharmacokinetic modeling of CYP2C8 substrate rosiglitazone and its metabolite to predict metabolic drug-drug interaction
Nilesh Gaud ... Maria Walczak
Drug Metabolism and Pharmacokinetics | VOL. -
Nilesh Gaud, et. al.Nilesh Gaud ... Maria Walczak
01 May 2024
Lysosomal trapping measurement in multiple cell types using a high content imaging (HCI) system
Johanna Pacsuta ... Zsuzsanna Gaborik
Drug Metabolism and Pharmacokinetics | VOL. 55
Johanna Pacsuta, et. al.Johanna Pacsuta ... Zsuzsanna Gaborik
01 Apr 2024
View more papers